Deutsche Bank’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,921
| Closed | -$64.2K | – | 3723 |
|
|
2025
Q1 | $64.2K | Hold |
8,921
| – | – | ﹤0.01% | 3292 |
|
|
2024
Q4 | $195K | Buy |
8,921
+7,568
| +559% | +$166K | ﹤0.01% | 3063 |
|
|
2024
Q3 | $27.2K | Hold |
1,353
| – | – | ﹤0.01% | 3396 |
|
|
2024
Q2 | $23.5K | Sell |
1,353
-407
| -23% | -$7.08K | ﹤0.01% | 3369 |
|
|
2024
Q1 | $73.4K | Buy |
+1,760
| New | +$73.4K | ﹤0.01% | 3240 |
|
|
2023
Q4 | – | Sell |
-2,041
| Closed | -$66.7K | – | 3640 |
|
|
2023
Q3 | $66.7K | Hold |
2,041
| – | – | ﹤0.01% | 3309 |
|
|
2023
Q2 | $119K | Buy |
+2,041
| New | +$119K | ﹤0.01% | 3188 |
|
|
2021
Q2 | – | Sell |
-348
| Closed | -$90K | – | 4632 |
|
|
2021
Q1 | $90K | Sell |
348
-32
| -8% | -$8.28K | ﹤0.01% | 3961 |
|
|
2020
Q4 | $73K | Buy |
380
+108
| +40% | +$20.7K | ﹤0.01% | 3922 |
|
|
2020
Q3 | $55K | Buy |
272
+19
| +8% | +$3.84K | ﹤0.01% | 3779 |
|
|
2020
Q2 | $71K | Buy |
253
+67
| +36% | +$18.8K | ﹤0.01% | 3578 |
|
|
2020
Q1 | $56K | Sell |
186
-62
| -25% | -$18.7K | ﹤0.01% | 3425 |
|
|
2019
Q4 | $78K | Buy |
248
+120
| +94% | +$37.7K | ﹤0.01% | 3624 |
|
|
2019
Q3 | $47K | Sell |
128
-48
| -27% | -$17.6K | ﹤0.01% | 3848 |
|
|
2019
Q2 | $78K | Buy |
176
+41
| +30% | +$18.2K | ﹤0.01% | 4168 |
|
|
2019
Q1 | $69K | Buy |
135
+99
| +275% | +$50.6K | ﹤0.01% | 4283 |
|
|
2018
Q4 | $14K | Sell |
36
-30
| -45% | -$11.7K | ﹤0.01% | 4450 |
|
|
2018
Q3 | $19K | Buy |
66
+17
| +35% | +$4.89K | ﹤0.01% | 4592 |
|
|
2018
Q2 | $32K | Buy |
49
+11
| +29% | +$7.18K | ﹤0.01% | 4597 |
|
|
2018
Q1 | $155K | Buy |
+38
| New | +$155K | ﹤0.01% | 4172 |
|